GLOB Global Med Technologies Inc. featured news, full reports, and detailed charts
Global Med Technologies Inc. (GLOB/GLOB.OB) Wrap Up:
Global Med Technologies, Inc. designs, develops, markets, and supports information management software products for blood banks, hospitals, centralized transfusion centers, and other health care related facilities in the United States, Africa, Canada, and the Caribbean. Its products include SafeTrace, which is used to assist community blood centers, hospitals, plasma centers, and outpatient clinics for the collection and management of blood and blood products; SafeTrace Tx, a transfusion management information system designed for hospitals and centralized transfusion centers to enable the quality of blood transfused into patient-recipients; and ElDorado Donor, a blood management software app...Global Med Technologies Inc. (GLOB:OTC Bulletin Board Market)
Snapshot of Global Med Technologies Inc. (GLOB)
|
OPEN
$0.75
|
PREVIOUS CLOSE
$0.80
|
|
|
DAY HIGH
$0.80
|
DAY LOW
$0.75
|
|
|
52 WEEK HIGH
09/21/09 - $1.14
|
52 WEEK LOW
03/10/09 - $0.31
|
|
|
MARKET CAP
29.1M
|
AVERAGE VOLUME 3 mo
54.9K
|
|
|
DILUTED EPS TTM
$0.01
|
SHARES OUTSTANDING
36.3M
|
|
|
GLOB Does Not Pay Dividends
|
P/E TTM
62.6x
|
|
| K = Thousands M = Millions B = Billions | ||
GLOB Top Compensated Officers
Executives, Board Directors
Key developments for Global Med Technologies Inc. (GLOB)
Global Med Technologies Inc. reported unaudited operating results for the third quarter and nine months ended September 30, 2009. The company reported record net income of $1.10 million or earnings of $0.02 per diluted common share, for the three months ended September 30, 2009 compared to a net loss of $228,000, or a loss of $0.01 per diluted common share for the comparable period in 2008. This represents a $1.33 million increase in net income for the third quarter of 2009 when compared with the comparable period in 2008. In the third quarter of 2009, operating income improved to $1.12 million from a $118,000 loss during the comparable 2008 period. Revenues were $7.3 million against $6.9 million a year ago. EBITDA was $1.5 million against $230,000 a year ago. For the first nine months of 2009, the company's revenues increased to $23.68 million or a 45% increase over the $16.38 million in revenues recognized during the comparable period in 2008. The company's third quarter revenues increased to $7.26 million representing a 5% increase from the $6.94 million in the comparable period in 2008. While the company's acquisitions of Inlog and eDonor in 2008 were the primary drivers of revenue growth for the three and nine months ended September 30, 2009, the company's organic business also experienced revenue growth during these periods when compared with the comparable periods during 2008. For the nine months ended September 30, 2009, income from operations improved to $2.80 million from $840,000 for the comparable period during 2008. The company's net income for the first nine months of 2009 was $1.70 million, or $0.04 per diluted common share outstanding, versus $284,000, or $0.01 per diluted common share, for the comparable period during 2008. The company's cash flow from operations for the first nine months of 2009 was $3.87 million, a more than 248% increase over the $1.11 million recorded for the first nine months of 2008. EBITDA was $3.85 million against $1.3 million a year ago.
Global Med Technologies Inc., Q3 2009 Earnings Call, Nov-11-2009
Effective as of October 14, 2009, the Board of Directors of Global Med Technologies Inc. has appointed Darren Craig to the position of Acting Chief Financial Officer. Mr. Craig, age 45, also serves as the company’s Vice President of Finance and has served a previous stint as the company’s Acting Chief Financial Officer. Mr. Craig has been an officer of the Company since October 2007 and has been with the company since October 2000.
GLOB Competitors
| Company | Last | Change |
| Cerner Corp | $75.84 USD | -0.04 |
| Eclipsys Corporation | $19.10 USD | -0.07 |
| Haemonetics Corp | $53.54 USD | -1.22 |
| McKesson Corp | $63.12 USD | +0.07 |
| MEDIWARE Information Systems Inc | $7.00 USD | -0.14 |
| Market data is delayed at least 20 minutes. | ||
Industry Analysis
| Valuation | GLOB | Industry Range |
| Price/Earnings | 27.8x |
|
| Price/Sales | 0.9x |
|
| Price/Book | 9.0x |
|
| Price/Cash Flow | 12.3x |
|
| TEV/Sales | 0.3x |
|
|
GLOB |
||
GLOB transactions
| Type Date |
Target |
|
Merger/Acquisition
October 6, 2009 |
Hemo-Net LLC |
